Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
6.81
0.21 (3.18%)
At close: Aug 15, 2025, 3:59 PM
6.82
0.15%
After-hours: Aug 15, 2025, 04:10 PM EDT
Fulcrum Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 42.59M | 42.18M | 58.21M | 72.63M | 86.7M | 39.95M | 25.56M | 30.08M | 33.97M | 34.73M | 35.1M | 90.94M | 40.15M | 33.31M | 35.41M | 65.47M | 56.78M |
Short-Term Investments | 171.52M | 184.43M | 182.81M | 184.6M | 187.08M | 173.37M | 210.66M | 227.01M | 244.2M | 263.11M | 167.82M | 130.85M | 128.82M | 161.8M | 182.75M | 174.87M | 68.77M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 1.2M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M |
Other Long-Term Assets | 1.22M | 1.21M | 1.21M | 1.28M | 3.21M | 1.99M | 2.01M | 1.99M | 2M | 2.03M | 2.1M | 2.1M | 2.11M | 816K | 542K | 519K | 531K |
Receivables | n/a | 979K | 3.34M | 3.66M | 3.53M | 1.08M | 2.25M | 1.68M | 656K | 1.26M | 1.08M | 1.24M | 1.49M | 1.21M | 4.11M | 1.56M | 823K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.1M | -1.41M | -1.17M | -852K | n/a | -392K | 3.7M | -1.61M | 4.25M | 2.13M |
Other Current Assets | 5.26M | 4.97M | n/a | 1.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | n/a | 38K | 11K |
Total Current Assets | 219.37M | 232.56M | 249.92M | 267.49M | 280.29M | 217.95M | 242.2M | 262.49M | 282.95M | 302.83M | 207.52M | 227.73M | 174.25M | 200.06M | 226M | 246.19M | 128.51M |
Property-Plant & Equipment | 8.25M | 8.88M | 9.58M | 10.24M | 10.77M | 11.45M | 12.39M | 13.31M | 14.3M | 15.17M | 15.97M | 16.89M | 17.79M | 18.28M | 7.37M | 7.75M | 7.75M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 9.46M | 10.09M | 10.79M | 11.52M | 13.97M | 14.64M | 15.49M | 16.39M | 17.39M | 18.29M | 19.17M | 20.08M | 20.99M | 20.18M | 9M | 9.36M | 9.37M |
Total Assets | 228.84M | 242.65M | 260.72M | 279.01M | 294.26M | 232.59M | 257.69M | 278.88M | 300.33M | 321.12M | 226.69M | 247.81M | 195.23M | 220.25M | 235M | 255.55M | 137.88M |
Account Payables | 1.75M | 1.51M | 1.16M | 4.04M | 3.58M | 3.86M | 2.76M | 3.57M | 3.91M | 3.78M | 3.64M | 2.73M | 5.38M | 6M | 4.79M | 3.74M | 4.5M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -2.03M | n/a | 334K | 513K | 737K | 934K | 1.39M | 1.78M | 2.92M | 4.71M | 6.13M | 9.9M |
Short-Term Debt | 2.29M | 2.24M | n/a | n/a | n/a | n/a | 2.19M | 2.35M | 2.51M | 2.66M | n/a | 2.54M | 2.48M | 2.43M | n/a | n/a | n/a |
Other Current Liabilities | 4.94M | 4.35M | 463K | 400K | 4.31M | 3.19M | 1.82M | 1.44M | 2.44M | 2.2M | 5.34M | 2.01M | 7.25M | 2.51M | 4.71M | 7.6M | 6.14M |
Total Current Liabilities | 8.98M | 8.1M | 11.04M | 14.51M | 12.7M | 10.69M | 13.68M | 14.07M | 14.8M | 14.41M | 16.73M | 14.7M | 22.12M | 18.29M | 19.2M | 20.6M | 22.51M |
Long-Term Debt | 5.28M | 5.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 197K | 197K | 197K | 197K | 197K | 197K | 197K | 197K | 447K | 320K | 197K | 197K | 197K | n/a | 4.26M | 4.34M | 4.48M |
Total Long-Term Liabilities | 5.47M | 6.06M | 6.64M | 7.21M | 7.77M | 8.3M | 8.83M | 9.34M | 10.1M | 10.46M | 11.02M | 11.69M | 12.36M | 12.8M | 4.26M | 4.34M | 4.48M |
Total Liabilities | 14.46M | 14.16M | 17.68M | 21.72M | 20.47M | 19M | 22.5M | 23.42M | 24.9M | 24.86M | 27.74M | 26.39M | 34.48M | 31.09M | 23.46M | 24.94M | 26.99M |
Total Debt | 7.57M | 8.11M | 8.63M | 9.14M | 9.65M | 10.14M | 10.82M | 11.49M | 12.16M | 12.8M | 13.42M | 14.04M | 14.64M | 15.23M | 469K | n/a | n/a |
Common Stock | 54K | 54K | 54K | 54K | 62K | 62K | 62K | 62K | 62K | 62K | 52K | 52K | 41K | 41K | 41K | 41K | 33K |
Retained Earnings | -554.35M | -537.05M | -519.4M | -502.83M | -481.13M | -536.54M | -509.67M | -484.92M | -460.9M | -437.12M | -412.34M | -386.2M | -362.46M | -328.39M | -302.47M | -278.98M | -258.27M |
Comprehensive Income | n/a | n/a | 130K | 379K | -366K | -434K | -136K | -886K | -1.2M | -651K | -797K | -921K | -1.07M | -1.09M | -397K | -87K | -9K |
Shareholders Equity | 214.38M | 228.49M | 243.03M | 257.29M | 273.79M | 213.59M | 235.19M | 255.46M | 275.43M | 296.26M | 198.94M | 221.41M | 160.75M | 189.16M | 211.54M | 230.61M | 110.89M |
Total Investments | n/a | 184.43M | 182.81M | 184.6M | 187.08M | 174.57M | 211.75M | 227.01M | 244.2M | 263.11M | 167.82M | 130.85M | 128.82M | 161.8M | 182.75M | 174.87M | 68.77M |